Showing results (71-80 of 293) with videos related to

Sort By:
Pageof 30
JAMA Cardiology|July 20, 2022
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical TrialKazuma Oyama, Itamar Raz, Avivit Cahn, et al.
Diabetes/Metabolism Research and Reviews|February 11, 2011
The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic ratsNomy Levin-Iaina, Adrian Iaina, Itamar Raz
International Reviews of Immunology|December 2, 2005
Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitusRoy Eldor, Irun R Cohen, Itamar Raz
Diabetes, Obesity & Metabolism|September 13, 2018
Acute renal outcomes with sodium-glucose co-transporter-2 inhibitors: Real-world data analysisAvivit Cahn, Cheli Melzer-Cohen, Rena Pollack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effectDavid Stepensky, Michael Friedman, Itamar Raz, et al.
Diabetes/Metabolism Research and Reviews|September 24, 2004
Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storageItamar Raz, Roi Eldor, Simona Cernea, et al.
Diabetes Technology & Therapeutics|February 24, 2007
Noninvasive continuous glucose monitoring using photoacoustic technology-results from the first 62 subjectsRam Weiss, Yevgeny Yegorchikov, Alexander Shusterman, et al.
Diabetes Research and Clinical Practice|June 16, 2005
Early use of insulin in type 2 diabetesRoy Eldor, Erwin Stern, Zvonko Milicevic, et al.
Harefuah|October 24, 2021
[COMPARISON OF A RECOMMENDATION FOR A DESIRABLE HBA1C VALUE BY INTERNAL WARD PHYSICIANS, DIABETES PHYSICIANS AND AN APPLICATION, FOR DIABETES PATIENTS DISCHARGED FROM HOSPITALIZATION IN AN INTERNAL WARD]Julio Wainstein, Gregory Luzovetsky, Hedi Auerbach, et al.
Clinical Therapeutics|December 7, 2005
Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover studySimona Cernea, Miriam Kidron, Jay Wohlgelernter, et al.
Pageof 30